Skip to main content
Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - Economic Times 22-Jun-2020
![](https://img.etimg.com/thumb/msid-76498900,width-1070,height-580,imgsize-425301,overlay-etmarkets/photo.jpg)
Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - Economic Times
If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
More...